GlassScriptPhysician profile
Rodney Roberts
NPI 1306847785
$4,299.82
in general payments reported to CMS, 2019-2025
35 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $394 · 2021: $675 · 2022: $699 · 2023: $779 · 2024: $764 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,157.58 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $375.40 | 2020-2024 | Vraylar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $362.72 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $322.32 | 2019-2024 | Trintellix |
| Lilly USA, LLC | $216.75 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Esperion Therapeutics, INC. | $203.61 | 2020-2024 | Nexletol |
| Amgen INC. | $155.68 | 2019-2024 | Krystexxa, Repatha, Otezla |
| Janssen Pharmaceuticals, INC | $132.34 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $129.83 | 2020-2024 | Airsupra, Farxiga |
| Pfizer INC. | $128.42 | 2019-2024 | |
| Phathom Pharmaceuticals, INC. | $111.82 | 2024-2025 | Voquezna |
| Genentech USA, INC. | $73.32 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $72.96 | 2023-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $69.12 | 2023-2024 | |
| Eisai INC. | $68.32 | 2020-2024 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.